Dr. Williams is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161
Summary
- Dr. Michelle Williams is a pathologist in Houston, TX and is affiliated with University of Texas M.D. Anderson Cancer Center. She received her medical degree from University of Florida College of Medicine and has been in practice 16 years. She specializes in anatomic pathology with expertise in head and neck and thyroid neoplasms.
Education & Training
- University of Texas M D Anderson Cancer CenterFellowship, Head and Neck Pathology, 2005 - 2006
- University of Texas M.D. Anderson Cancer CenterSelective Pathology, 2004 - 2005
- University of FloridaResidency, Pathology-Anatomic and Clinical, 2001 - 2004
- University of Florida College of MedicineInternship, Transitional Year, 2000 - 2001
- University of Florida College of MedicineClass of 2000
- University of Central FloridaB.S., Molecular and Microbiology, Summa Cum Laude, 1996
Certifications & Licensure
- TX State Medical License 2006 - 2025
- FL State Medical License 2003 - 2016
- American Board of Pathology Anatomic Pathology & Clinical Pathology
Awards, Honors, & Recognition
- Honorable Mention Award 2012
- Best Platform Presentation in Head and Neck Pathology 2005
- Founders' Scholars Award University of Central Florida, 1996
- Join now to see all
Publications & Presentations
PubMed
- Prognostic Impact of Notch1 Intracellular Domain, P63, and c-MYC in Lacrimal Gland Adenoid Cystic Carcinoma.Jiawei Zhao, Michelle D Williams, Mike Hernandez, Grace Kuang, Hila Goldberg
Investigative Ophthalmology & Visual Science. 2024-09-03 - 2 citationsOral Pre-malignancy: An Update on Novel Therapeutic Approaches.Shorook Naara, Clara Andrews, Andrew Sikora, Michelle Williams, Mark Chambers
Current Oncology Reports. 2024-09-01 - 3 citationsInitial Management of BRAF V600E-Variant Anaplastic Thyroid Cancer: The FAST Multidisciplinary Group Consensus Statement.Sarah Hamidi, Ramona Dadu, Mark E Zafereo, Renata Ferrarotto, Jennifer R Wang
JAMA Oncology. 2024-09-01
Journal Articles
- Active Surveillance for Prostate and Thyroid Cancers: Evolution in Clinical Paradigms and Lessons LearnedSpyridon P Basourakos, Patricia Troncoso, Michelle D Williams, Jeri Kim, Nature
- Expression of PTEN, Androgen Receptor, HER2/neu, Cytokeratin 5/6, Estrogen Receptor-Beta, HMGA2, and PLAG1 in Salivary Duct CarcinomaDiana Bell, Michelle D Williams, Head and Neck Pathology
- Ear and Temporal Bone: Cartilaginous and Osseous PathologiesMichelle Williams, MD, Head and Neck Pathology
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Epidermal Growth Factor Receptor Over-expression in Thyroid Neoplasia Associates with Chromosome 7 PolysomyWilliams MD, Cabanillas ME, Clayman GL, Modern Pathology, 1/1/2010
- Expression of Epidermal Growth Factor Family of Receptors in Salivary Duct Carcinomas: Comparative Methods and Targeted TherapyWilliams MD, Kies MS, Weber RS, El-Naggar AK, Modern Pathology, 1/1/2008
- Join now to see all
Lectures
- Use of Molecular Diagnostics in the Classification of Thyroid NeoplasiaGuangzhou, China - 6/1/2013
- Use of Molecular Diagnostics in the Classification of Thyroid NodulesHollywood, FL - 5/13/2013
- Head and Neck Pathology: Evolving Testing for Diagnosos and PrognosisHollywood, FL - 5/12/2013
- Join now to see all
Professional Memberships
- Fellow
- Member
- Member
- Endocrine Pathology SocietyMember
- American Head and Neck Pathology SocietyMember
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: